Aprea Therapeutics, Inc. (APRE) vs Jasper Therapeutics, Inc. (JSPR)
A side-by-side comparison of Aprea Therapeutics, Inc. and Jasper Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APRE
Aprea Therapeutics, Inc.
$0.64HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
JSPR
Jasper Therapeutics, Inc.
$0.55HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — APRE vs JSPR
growth of $100 · dividends reinvested · last 7yAPRE -99.9% (-63.8%/yr)JSPR -99.4% (-51.8%/yr)JSPR compounded faster over this window
Log scale — wide-divergence pair
APRE JSPR
APRE vs JSPR: by the numbers
- •JSPR is the larger company ($9M vs $8M market cap).
Metrics side by side
Valuation
| Metric | APRE | JSPR |
|---|---|---|
| P/B ratio | 0.20 | 6.36 |
Profitability
| Metric | APRE | JSPR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -31.99% | -2248.48% |
| ROIC | -33.73% | -1394.09% |
Growth (annualized)
| Metric | APRE | JSPR |
|---|---|---|
| Total return CAGR (5Y) | -63.30% | -62.51% |
Frequently asked
- How have APRE and JSPR total returns compared?
- Over the past 5 years, APRE delivered -63.30% and JSPR delivered -62.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.